Aortoesophageal fistula is rare but fatal if untreated. Open thoracic surgery is associated with high operative mortality and morbidity. We report a case of a 77-year-old man who, treated with thoracic endovascular aortic repair (TEVAR) for descending thoracic aneurysm in another center, after an acute episode of hematemesis and melena was referred to our center. The total body computed tomography scan showed the presence of reperfusion of the descending thoracic aneurysm sac (8.8 cm in diameter) in the proximal and distal TEVAR landing zone (endoleak type I) without clear signs of fistulous tract with the esophageal lumen. The patient underwent new TEVAR inside previous implantation with proximal landing very close to left subclavian artery and distal landing just above celiac trunk. For the presence of a tracheoesophageal fistula, an esophageal endoprosthesis was implanted few days later, and a jejunostomy was performed. At 30 days, patient was in good general condition, but he died at 3 months' follow-up. Aortoesophageal fistula is a rare and usually fatal condition; early recognition and TEVAR treatment prevent immediate exsanguination in patients, but after deployment of the endograft, most patients are at risk for infectious complications. Cessation of bleeding and restoration of circulation is of paramount urgency, but infectious diseases and esophageal repair remain open problems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.avsg.2011.06.009 | DOI Listing |
Ann Thorac Surg Short Rep
September 2024
Department of Cardiothoracic Surgery, Loma Linda University Health, Loma Linda, California.
A 39-year-old man with past medical history of type A aortic dissection presented to the emergency department with hematemesis, hypotension, and tachycardia. Imaging revealed an aortoesophageal fistula. The patient was taken emergently for thoracic endovascular aortic repair to cover the area of potential fistula.
View Article and Find Full Text PDFAnn Thorac Surg Short Rep
September 2024
Department of Cardiovascular Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Background: The aortoesophageal fistula (AEF) caused by thoracic endovascular aortic repair is a challenging condition. Traditional treatment approaches have been associated with high mortality and morbidity. This study introduces a modified single-stage surgical strategy that aims to optimize outcomes and to reduce the risk of recurrence for AEF.
View Article and Find Full Text PDFGastro Hep Adv
August 2024
Gastroenterology Department, Hennepin Healthcare, Minneapolis, Minnesota.
Ann Vasc Surg
December 2024
Department of Cardiac and Vascular Surgery, University Medical Centre Mainz, Johannes Gutenberg University, Mainz, Germany.
An aorto-esophageal fistula (AOF) is a pathological communication between the thoracic aorta and the esophagus. It can induce life-threatening hematemesis, which is unique among the other types of gastrointestinal hemorrhage in that the vomiting is bright red and represents an arterial bleed. Nevertheless, it is notable that over 70% of cases are associated with thoracic aortic aneurysms, particularly as a postoperative complication following open surgery, and arguably more so following endovascular repair.
View Article and Find Full Text PDFEur Heart J Case Rep
December 2024
Department of Cardiovascular Surgery, Higashiosaka City Medical Center, 3-4-5, Nishiiwata, Higashiosaka, Osaka 578-8588, Japan.
Background: Aortoesophageal fistula (AEF) is a life-threatening disease that causes massive bleeding, sepsis, and ultimately death. Therefore, emergency treatments are required. Recently, cases of AEF treated with thoracic endovascular aortic repair (TEVAR) have been reported.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!